Overall rank by patents
#44,472
Across all tracked assignees
USPTO PatentsView assignee record - 5 granted patents across 10 technology areas, active 2016–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: H10N (ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR).
The verdict
Akita holds 5 US patents across 10 technology areas, rank #44,472 of 50,000 tracked assignees.
Akita Prefecture has been granted 5 US utility patents between 2016 and 2025, placing Akita Prefecture at rank #44,472 across all assignees tracked by PlainPatent. This portfolio spans 10 distinct Cooperative Patent Classification (CPC) subclasses, averaging 8.6 claims per patent with primary concentration in H10N (ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR). As a Foreign Government, Akita Prefecture is one of the more focused assignees in the PatentsView dataset. By volume, Akita sits between Aiviva Biopharma, Inc. (5 patents, rank #44,468) and Albea Lacrost (5 patents, rank #44,476) - the closest US assignees by grant volume. The composite Innovation Score of 29.2/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 3 grants, compared with 2 in the 2015–2019 window, a +50% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The Foreign Government classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Akita Prefecture's 8.6 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while concentration in 10 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Akita Prefecture against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
AIVIVA BIOPHARMA, INC.
5 patents
AJ1E Superior Solutions, LLC
5 patents
AJAX SYSTEMS CYPRUS HOLDINGS LTD
5 patents
AKI, Inc.
5 patents
AKOS BIOSCIENCES, INC.
5 patents
AKRION SYSTEMS, LLC
5 patents
AKWEL SWEDEN AB
5 patents
ALBEA LACROST
5 patents
AKITA PREFECTURE
5 patents
What this shows Akita holds 5 patents at rank #44,472, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #44,472 in granted patent volume.
Other assignees with the most granted patents in Akita's primary technology class.
Akita's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
29 Top 70% higher than 30% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 2 | 40.0% |
| 2021 | 1 | 20.0% |
| 2024 | 1 | 20.0% |
| 2025 | 1 | 20.0% |
Top 10 of 10 technology areas
Overall rank by patents
#44,472
Across all tracked assignees
29.2 out of 100
How to use this portfolio
Akita's 5 grants land it in the top 70% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.